We are excited to announce that Singota Solutions (Bloomington, Indiana CDMO specializing in aseptic filling) is featured in the May issue of Drug Development & Delivery’s Special Cover Feature on Prefilled Syringes & Parenteral Delivery: Next-Gen Injections Feature Technology & Reconstitution. This special feature highlights innovative advancements in injection technology and reconstitution processes. Singota Solutions’ contribution to this cover feature emphasizes our cutting-edge solutions and expertise in the field, showcasing our commitment to advancing drug development and delivery.
In the May issue of Drug Development & Delivery, Singota Solutions is featured in a special cover story highlighting advancements in Prefilled Syringes (PFS) and Parenteral Delivery technologies. Singota Solutions, a US-based CDMO, specializes in formulation development and aseptic fill/finish for injectable biotech projects. Utilizing state-of-the-art robotic aseptic filling technology within a gloveless work cell, Singota ensures highly repeatable and precise fills for small-batch manufacturing. This is ideal for producing preclinical and clinical injectable products in prefilled syringe, vial, and cartridge formats with minimized line losses.
The feature details Singota’s extensive capabilities, including formulation and analytical development, stability studies, and clinical batch production. Will Powers, Senior Director of Business Development, shares a case study on the development of an injectable peptide drug for hematologic and blood disorders. Over several years, Singota provided comprehensive support from formulation development to Phase III clinical trials, including lyophilization process studies. This work illustrates the growing demand for PFS, driven by the need for improvements in quality, convenience, cost of administration, and patient monitoring.
Singota’s contributions emphasize the benefits of using PFS, such as eliminating the need to transfer products from vials to syringes, thereby reducing costs and dosing errors while improving product quality, safety, and reliability. The article underscores Singota’s commitment to leveraging advanced technologies to enhance the lives of patients through efficient and innovative drug delivery solutions. Read the full feature to learn more about Singota’s pioneering role in the field.
Read the full article HERE.